Cargando…

Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality

Detalles Bibliográficos
Autores principales: Maloberti, A., Giannattasio, C., Rebora, P., Occhino, G., Ughi, N., Rizzo, J., Fabbri, S., Leidi, F., Cartella, I., Algeri, M., Scarpellini, S., Rossetti, C., Epis, O.M., Molon, G., Bonfanti, P., Valsecchi, M.G., Genovesi, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425751/
http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.769
_version_ 1784778517530017792
author Maloberti, A.
Giannattasio, C.
Rebora, P.
Occhino, G.
Ughi, N.
Rizzo, J.
Fabbri, S.
Leidi, F.
Cartella, I.
Algeri, M.
Scarpellini, S.
Rossetti, C.
Epis, O.M.
Molon, G.
Bonfanti, P.
Valsecchi, M.G.
Genovesi, S.
author_facet Maloberti, A.
Giannattasio, C.
Rebora, P.
Occhino, G.
Ughi, N.
Rizzo, J.
Fabbri, S.
Leidi, F.
Cartella, I.
Algeri, M.
Scarpellini, S.
Rossetti, C.
Epis, O.M.
Molon, G.
Bonfanti, P.
Valsecchi, M.G.
Genovesi, S.
author_sort Maloberti, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9425751
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-94257512022-08-30 Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality Maloberti, A. Giannattasio, C. Rebora, P. Occhino, G. Ughi, N. Rizzo, J. Fabbri, S. Leidi, F. Cartella, I. Algeri, M. Scarpellini, S. Rossetti, C. Epis, O.M. Molon, G. Bonfanti, P. Valsecchi, M.G. Genovesi, S. Atherosclerosis Article Published by Elsevier B.V. 2022-08 2022-08-30 /pmc/articles/PMC9425751/ http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.769 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Maloberti, A.
Giannattasio, C.
Rebora, P.
Occhino, G.
Ughi, N.
Rizzo, J.
Fabbri, S.
Leidi, F.
Cartella, I.
Algeri, M.
Scarpellini, S.
Rossetti, C.
Epis, O.M.
Molon, G.
Bonfanti, P.
Valsecchi, M.G.
Genovesi, S.
Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality
title Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality
title_full Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality
title_fullStr Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality
title_full_unstemmed Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality
title_short Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality
title_sort atrial fibrillation incidence in sars-cov-2 infected patients: predictors and relationship with in-hospital mortality
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425751/
http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.769
work_keys_str_mv AT malobertia atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT giannattasioc atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT reborap atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT occhinog atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT ughin atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT rizzoj atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT fabbris atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT leidif atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT cartellai atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT algerim atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT scarpellinis atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT rossettic atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT episom atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT molong atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT bonfantip atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT valsecchimg atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality
AT genovesis atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality